This conference covers all areas of inquiry in cancer immunology and immunotherapy.
Leading National Cancer Groups Release Joint Statement to Chart the Future of Cancer Health Disparities Research
COX-2 Inhibitors May Reverse IDO1-mediated Immunosuppression in Some Cancers
Insurance Approval Rates for Clinical Trial Participation Rose Under Affordable Care Act
Turning the Tide Against Cancer 2017 National Conference Brings the Patient Voice to Oncology Policy, Research, and Care
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, Sept. 6-9, 2017
Conference on The Science of Cancer Health Disparities, Sept. 25-28, 2017
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Oct. 26-30, 2017
San Antonio Breast Cancer Symposium, Dec. 5-9, 2017
This Cancer Research Catalyst blog post discusses recent decisions by the FDA that are significantly advancing the field of precision medicine.
Former AACR President Tom Curran, PhD, spoke with Forbes about the challenges faced when treating glioblastoma and other brain cancers.